Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)
TipRanks4minutes ago
BioMarin Pharmaceutical Investors Overfocused on Roctavian, Distracted From Enzyme Replacement Therapies, UBS Says
BioMarin Pharmaceutical (BMRN) investors were surprised by lower-than-expected sales of one-time gene therapy Roctavian, a treatment for adults with severe hemophilia A, UBS said in a note Monday. On
MT Newswires14:26 ET
US MOVERS&SHAKERS Apr 22-Apr 26, 2024
Here are the top 10 gainers and losers of the week.
moomoo NewsApr 26 19:15 ET
BioMarin Pharmaceutical Price Target Cut to $112.00/Share From $115.00 by Morgan Stanley
BioMarin Pharmaceutical Price Target Cut to $112.00/Share From $115.00 by Morgan Stanley
Dow JonesApr 26 12:49 ET
Biomarin Pharmaceutical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 37.05% Morgan Stanley $115 → $112 Maintains Overweight 04/26/2024 8.91% Canaccord Genuity $91 →
BenzingaApr 26 12:38 ET
BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity
BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity
Dow JonesApr 26 08:58 ET
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Yahoo FinanceApr 26 08:49 ET
Express News | Canaccord Genuity Maintains Hold on Biomarin Pharmaceutical, Lowers Price Target to $89
BenzingaApr 26 08:48 ET
Results: BioMarin Pharmaceutical Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shareholders are probably feeling a little disappointed, since its shares fell 8.8% to US$82.17 in the week after its latest quarterly results. It look
Simply Wall StApr 26 07:14 ET
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)
TipRanksApr 26 05:27 ET
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Earnings and Voxzogo's Growth Potential
TipRanksApr 26 01:57 ET
Top Gap Ups and Downs on Thursday: META, AZN, CAT and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
moomoo NewsApr 25 20:13 ET
BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup
BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup
Dow JonesApr 25 18:59 ET
Express News | Citigroup Maintains Neutral on Biomarin Pharmaceutical, Lowers Price Target to $91
BenzingaApr 25 18:48 ET
BioMarin Pharmaceutical Down Over 8%, on Pace for Largest Percent Decrease Since January 2021 -- Data Talk
BioMarin Pharmaceutical Inc. (BMRN) is currently at $83.42, down $7.78 or 8.53% --Would be lowest close since Nov. 13, 2023, when it closed at $83.39 --On pace for largest percent decrease since Jan
Dow JonesApr 25 14:59 ET
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
BenzingaApr 25 13:57 ET
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
In the preceding three months, 8 analysts have released ratings for Biomarin Pharmaceutical (NASDAQ:BMRN), presenting a wide array of perspectives from bullish to bearish.The table below provides a co
BenzingaApr 25 12:01 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Biomarin Pharmaceutical, Maintains $110 Price Target
BenzingaApr 25 10:34 ET
BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo
BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo
Dow JonesApr 25 10:28 ET
Express News | Biomarin Pharmaceutical Shares Down 8.1% After Q1 Rev Miss
ReutersApr 25 09:45 ET
No Data
No Data